- Advertisement -

Related

Brummer & Partners redeems Zenit and Canosa, to add Talarium

- Advertisement -

Stockholm (HedgeNordic) – The new year brings big changes for Brummer & Partners as the Swedish hedge fund giant makes changes in the allocations to their multi manager fund. On their website today, the manager announced that with February 29th 2016 Brummer Multi-Strategy (BMS) will redeeem all its shares in two funds, Zenit and Canosa.

Zenit started in July 1996 and was Sweden’s first hedge fund, and the first fund in the Brummer & Partners family of funds and while Canosa was one of BMS most recent additions. The multi-strategy fund had only been invested in Canosa since Canosas launch in May 2013.

Zenits Board has already decided to discontinue the active management of the fund. Zenit’s portfolio has been essentially eliminated, and when the withdrawal is completed, the Fund will no longer be burdened with any management fee.

„BMS decision to redeem their entire investment in Zenit and Canosa is based on general findings, where we can observe weak marginal contribution to BMS returns in recent years“, says BMS manager Klaus Jäntti in a statement.

Following the redemptions, BMS will only be invested in the funds Bodenholm, Florin Court, Lynx, Manticore, MNJ, Nektar and Observatory. Brummer & Partners did announce, later this year, BMS will be adding a new a new fund, Talarium Capital which will be operating out of Brummers´London office and focusing on European equities managed by Marko Soldo.

„We are delighted to welcome Marko Soldo and his team to the group. Marko has extensive experience in stock selection from his most recent role as a portfolio manager at Millennium Capital and previously from GMT Capital where he built up the Europe office. The fund is expected to contribute to the BMS risk-adjusted returns,” says Klaus Jäntti, portfolio manager of BMS.

BMS returned 2,4% (est.) in 2015 while the Nordic Hedge Index (NHX) FoHF sub index returned 2%.

Picture: (c) violetkaipa—shutterstock.com

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Kamran Ghalitschi
Kamran Ghalitschi
Kamran has been working in the financial industry since 1994 and has specialized on client relations and marketing. Having worked with retail clients in asset management and brokerage the first ten years of his career for major European banks, he joined a CTA / Managed Futures fund with 1,5 Billion USD under management where he was responsible for sales, client relations and operations in the BeNeLux and Nordic countries. Kamran joined a multi-family office managing their own fund of hedgefunds with 400 million USD AuM in 2009. Kamran has worked and lived in Vienna, Frankfurt, Amsterdam and Stockholm. Born in 1974, Kamran today again lives in Vienna, Austria.

Latest Articles

Systematic Multi-Strategy as a Portfolio Diversifier

By Fredrik Langenskiöld – Union Bancaire Privée: Multi-strategy funds are those that allocate to more than one alternative strategy or portfolio manager (PM) in...

Visio Allocator Delivers Record Month on AI Chip Rally

After a more muted, albeit still challenging, first quarter, multi-strategy fund Visio Allocator regained momentum starting in April and delivered its strongest month on...

Colosseum’s Difficult Stretch Continues as Co-Portfolio Manager Departs

After a volatile journey since launching in mid-2025, Colosseum Global Alpha has suffered two consecutive months of steep losses, leaving the fund down more...

CABA Offers Another Roll Down the Curve

CABA Capital has launched the fourth iteration of its Flex strategy, a three-year closed-ended AAA-yield premium strategy designed to harvest roll-down and pull-to-par effects...

Even Steven for Nordic CTAs in Mediocre May

May was another month characterized by reversals and cross-asset volatility. Strong momentum in U.S. equities contrasted with directionless moves across other markets, creating a...

Rhenman Doubles Down on Smaller Healthcare Innovators with New Fund

Many of healthcare’s most transformative breakthroughs often originate not from established industry giants, but from smaller companies developing new technologies, therapies, and treatment approaches....

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -